Analysis of prevalence, risk factors, and potential costs of unnecessary drug therapy in patients with chronic diseases at the outpatient setting

References

• Jakovljevic M, Getzen TE. Growth of global health spending share in low and middle income countries. Front Pharmacol. 2016;7:21.
   PubMed Web of Science ®Google Scholar
• The World Medicines Situation 2011 -Medicine expenditures [Internet]. [cited 2019 Feb 11]. Available from: http://apps.who.int/medicinedocs/en/m/abstract/Js18767en/.
   Google Scholar
• Rahmawati F, Pramantara I, Rohmah W, et al. Polypharmacy and unnecessary drug therapy on geriatric hospitalized patients in yogyakarta hospitals, Indonesia. Int J Pharm Pharm Sci. 2009;1:6–11.
   Google Scholar
• Shah BM, Hajjar ER. Polypharmacy, adverse drug reactions, and geriatric syndromes. Clin Geriatr Med. 2012;28:173–186.
   PubMed Web of Science ®Google Scholar
• Al-Azzam SI, Alzoubi KH, AbuRuz S, et al. Drug-related problems in a sample of outpatients with chronic diseases: a cross-sectional study from Jordan. Ther Clin Risk Manag. 2016;12:233–239.
   PubMed Web of Science ®Google Scholar
• AbuRuz SM, Bulatova NR, Yousef A-M-M, et al. Comprehensive assessment of treatment related problems in hospitalized medicine patients in Jordan. Int J Clin Pharm. 2011;33:501.
   PubMed Web of Science ®Google Scholar
• StataCorp. Stata statistical software: release 13. College Station, TX: StataCorp LP; 2013.
   Google Scholar
• Joint Procurement Department [Internet]. [cited 2018 Nov 4]. Available from: https://jordan.gov.jo/wps/portal/Home/GovernmentEntities/Ministries/Ministry/Ministry%20of%20Health/Joint%20Procurement%20Department?current=true&nameEntity=Joint%20Procurement%20Department&entityType=sub.
   Google Scholar
• oracle. Population – department of Statistics [Internet]. cited 2019 Feb 11. Available from: http://dosweb.dos.gov.jo/population/population-2/.
   Google Scholar
• 30% of adult Jordanians suffer a chronic illness — cancer centre official | Jordan Times [Internet]. [ cited 2018 Nov 8]. Available from: http://www.jordantimes.com/news/local/30-adult-jordanians-suffer-chronic-illness-%E2%80%94-cancer-centre-official.
   Google Scholar
• Al Khaja KAJ, Ahmed Isa H, Veeramuthu S, et al. Potentially inappropriate prescribing in older adults with hypertension or diabetes mellitus and hypertension in a primary care setting in Bahrain. MPP. 2018;27:241–249.
   Google Scholar
• Laidig F, May M, Brinkmann J, et al. Evaluation of potential prescribing errors in patients with polypharmacy: a method to improve medication safety in ambulatory care. Drugs Ther Perspect. 2018;34:322–334.
   Google Scholar
• Anrys PMS, Strauven GC, Foulon V, et al. Potentially inappropriate prescribing in belgian nursing homes: prevalence and associated factors. J Am Med Dir Assoc. 2018;19:884–890.
   PubMed Web of Science ®Google Scholar
• Kaufman DW, Kelly JP, Rosenberg L, et al. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. Jama. 2002;287:337–344.
   PubMed Web of Science ®Google Scholar
• Schuler J, Dückelmann C, Beindl W, et al. Polypharmacy and inappropriate prescribing in elderly internal-medicine patients in Austria. Wien Klin Wochenschr. 2008;120:733.
   PubMed Web of Science ®Google Scholar
• Prithviraj GK, Koroukian S, Margevicius S, et al. Patient characteristics associated with polypharmacy and inappropriate prescribing of medications among older adults with cancer. J Geriatr Oncol. 2012;3:228–237.
   PubMed Web of Science ®Google Scholar
• Steinman MA, Landefeld CS, Rosenthal GE, et al. Polypharmacy and prescribing quality in older people. J Am Geriatr Soc. 2006;54:1516–1523.
   PubMed Web of Science ®Google Scholar
• Moriarty F, Hardy C, Bennett K, et al. Trends and interaction of polypharmacy and potentially inappropriate prescribing in primary care over 15 years in Ireland: a repeated cross-sectional study. BMJ Open. 2015;5:e008656.
   PubMed Web of Science ®Google Scholar
• Abdulah R, Insani WN, Destiani DP, et al. Polypharmacy leads to increased prevalence of potentially inappropriate medication in the Indonesian geriatric population visiting primary care facilities. Ther Clin Risk Manag. 2018;14:1591–1597.
   PubMed Web of Science ®Google Scholar
• Reeve E, Gnjidic D, Long J, et al. A systematic review of the emerging definition of ‘deprescribing’with network analysis: implications for future research and clinical practice. Br J Clin Pharmacol. 2015;80:1254–1268.
   PubMed Web of Science ®Google Scholar
• Reeve E, Low L-F, Shakib S, et al. Development and validation of the revised Patients’ Attitudes Towards Deprescribing (rPATD) questionnaire: versions for older adults and caregivers. Drugs Aging. 2016;33:913–928.
   PubMed Web of Science ®Google Scholar
• Maturo A. Medicalization: current concept and future directions in a bionic society. Mens Sana Monogr. 2012;10:122–133.
   PubMedGoogle Scholar
• Westberg SM, Derr SK, Weinhandl ED, et al. Drug therapy problems identified by pharmacists through comprehensive medication management following hospital discharge. J Pharm Technol. 2017;33:96–107.
   Web of Science ®Google Scholar
• Heidelbaugh JJ, Goldberg KL, Inadomi JM. Overutilization of proton pump inhibitors: a review of cost-effectiveness and risk [corrected]. Am J Gastroenterol. 2009;104(Suppl 2):S27–S32.
   PubMedGoogle Scholar
• Bradley MC, Fahey T, Cahir C, et al. Potentially inappropriate prescribing and cost outcomes for older people: a cross-sectional study using the Northern Ireland enhanced prescribing database. Eur J Clin Pharmacol. 2012;68:1425–1433.
   PubMed Web of Science ®Google Scholar
• Savarino V, Dulbecco P, de Bortoli N, et al. The appropriate use of proton pump inhibitors (PPIs): need for a reappraisal. Eur J Intern Med. 2017;37:19–24.
   PubMed Web of Science ®Google Scholar
• Forgacs I, Loganayagam A. Overprescribing proton pump inhibitors. BMJ. 2008;336:2–3.
   PubMed Web of Science ®Google Scholar
• Institute of Medicine (US) Committee on Health Literacy. Health Literacy: A Prescription to End Confusion [Internet]. Nielsen-Bohlman L, Panzer AM, Kindig DA, editors. Washington (DC): National Academies Press (US); 2004 [cited 2018 Dec 3]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK216032/.
   Google Scholar
• Saqib A, Atif M, Ikram R, et al. Factors affecting patients’ knowledge about dispensed medicines: a qualitative study of healthcare professionals and patients in Pakistan. PLoS One. Internet. 2018;13 [cited 2019 Apr 16]. Available from. ;. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983558/
   Web of Science ®Google Scholar
• Masoudi FA, Krumholz HM. Polypharmacy and comorbidity in heart failure. BMJ. 2003;327:513–514.
   PubMedGoogle Scholar
• Dunn SP, Holmes DR, Moliterno DJ. Drug–drug interactions in cardiovascular catheterizations and interventions. JACC Cardiovasc Interv. 2012;5:1195–1208.
   PubMed Web of Science ®Google Scholar
• Morgan SG, Hunt J, Rioux J, et al. Frequency and cost of potentially inappropriate prescribing for older adults: a cross-sectional study. CMAJ Open. 2016;4:E346–E351.
   PubMedGoogle Scholar
• Hyttinen V, Jyrkkä J, Valtonen H. A systematic review of the impact of potentially inappropriate medication on health care utilization and costs among older adults. Med Care. 2016;54:950–964.
   PubMed Web of Science ®Google Scholar
• Heider D, Matschinger H, Meid AD, et al. Health service use, costs, and adverse events associated with potentially inappropriate medication in old age in Germany: retrospective matched cohort study. Drugs Aging. 2017;34:289–301.
   PubMed Web of Science ®Google Scholar
• Rankin A, Cadogan CA, Patterson SM, et al. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev. 20189:CD008165.
   PubMedGoogle Scholar